Lorenzo Leggio, a section chief with the National Institutes of Health (NIH), will discuss neuropharmacological treatments for alcoholism in the final seminar in the Research Institute on Addictions’ (RIA) Spring Seminar Series.

The lecture will take place at 10 a.m. May 22 in Room 132 at RIA, 1021 Main St., on UB’s Downtown Campus. It is free and open to the public.

Leggio is chief of the joint National Institute on Alcohol Abuse and Alcoholism-National Institute on Drug Abuse Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology at NIH in Bethesda, Maryland. He also is an adjunct associate professor in the Department of Behavioral and Social Sciences at Brown University. His clinical research is focused primarily on the pharmacological treatment of alcohol use disorder (AUD) and on the medical consequences of AUD, specifically liver disease.